These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


197 related items for PubMed ID: 11353879

  • 1. 24-hour glycemic profile in type 2 diabetic patients treated with gliclazide modified release once daily.
    Guillausseau PJ, Greb W.
    Diabetes Metab; 2001 Apr; 27(2 Pt 1):133-7. PubMed ID: 11353879
    [Abstract] [Full Text] [Related]

  • 2. The DIACOM study (effect of DosIng frequency of oral Antidiabetic agents on the COMpliance and biochemical control of type 2 diabetes).
    Kardas P.
    Diabetes Obes Metab; 2005 Nov; 7(6):722-8. PubMed ID: 16219016
    [Abstract] [Full Text] [Related]

  • 3. Daily blood glucose profiles of glibenclamide and gliclazide taken once or twice daily in elderly type 2 diabetic patients.
    Kigawa Y, Oba K, Futami-Suda S, Norose J, Yasuoka H, Suzuki K, Ouchi M, Watanabe K, Suzuki T, Nakano H.
    Geriatr Gerontol Int; 2008 Sep; 8(3):160-5. PubMed ID: 18821999
    [Abstract] [Full Text] [Related]

  • 4. A long-term comparison of pioglitazone and gliclazide in patients with Type 2 diabetes mellitus: a randomized, double-blind, parallel-group comparison trial.
    Charbonnel BH, Matthews DR, Schernthaner G, Hanefeld M, Brunetti P, QUARTET Study Group.
    Diabet Med; 2005 Apr; 22(4):399-405. PubMed ID: 15787663
    [Abstract] [Full Text] [Related]

  • 5. The effect of short-term glycemic regulation with gliclazide and metformin on postprandial lipemia.
    Emral R, Köseoğlulari O, Tonyukuk V, Uysal AR, Kamel N, Corapçioğlu D.
    Exp Clin Endocrinol Diabetes; 2005 Feb; 113(2):80-4. PubMed ID: 15772898
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of once- or twice-daily extended release metformin compared with thrice-daily immediate release metformin in type 2 diabetes mellitus.
    Bhansali A, Masoodi SR.
    J Assoc Physicians India; 2005 May; 53():441-5. PubMed ID: 16124352
    [Abstract] [Full Text] [Related]

  • 7. Effects of once-weekly dosing of a long-acting release formulation of exenatide on glucose control and body weight in subjects with type 2 diabetes.
    Kim D, MacConell L, Zhuang D, Kothare PA, Trautmann M, Fineman M, Taylor K.
    Diabetes Care; 2007 Jun; 30(6):1487-93. PubMed ID: 17353504
    [Abstract] [Full Text] [Related]

  • 8. [Free radical scavenging activity of sulfonylureas: a clinical assessment of the effectiveness of gliclazide].
    Jennings PE, Belch JJ.
    Ter Arkh; 2001 Jun; 73(4):27-31. PubMed ID: 11494442
    [Abstract] [Full Text] [Related]

  • 9. Maintenance of glycaemic control with the evening administration of a long acting sulphonylurea in male type 2 diabetic patients undertaking the Ramadan fast.
    Zargar AH, Siraj M, Jawa AA, Hasan M, Mahtab H.
    Int J Clin Pract; 2010 Jul; 64(8):1090-4. PubMed ID: 20455956
    [Abstract] [Full Text] [Related]

  • 10. A comparative study of insulin lispro and human regular insulin in patients with type 2 diabetes mellitus and secondary failure of oral hypoglycemic agents.
    Ross SA, Zinman B, Campos RV, Strack T, Canadian Lispro Study Group.
    Clin Invest Med; 2001 Dec; 24(6):292-8. PubMed ID: 11767232
    [Abstract] [Full Text] [Related]

  • 11. Combination therapy with insulin and oral agents: optimizing glycemic control in patients with type 2 diabetes mellitus.
    Yki-Järvinen H.
    Diabetes Metab Res Rev; 2002 Dec; 18 Suppl 3():S77-81. PubMed ID: 12324990
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of gliclazide in the treatment of non-insulin-dependent diabetes mellitus: a Canadian multicenter study.
    Mailhot J.
    Clin Ther; 1993 Dec; 15(6):1060-8. PubMed ID: 8111803
    [Abstract] [Full Text] [Related]

  • 13. Sitagliptin 100 mg daily effect on DPP-4 inhibition and compound-specific glycemic improvement.
    Alba M, Sheng D, Guan Y, Williams-Herman D, Larson P, Sachs JR, Thornberry N, Herman G, Kaufman KD, Goldstein BJ.
    Curr Med Res Opin; 2009 Oct; 25(10):2507-14. PubMed ID: 19691426
    [Abstract] [Full Text] [Related]

  • 14. [The efficacy and safety of 30 mg slow-released-gliclazide in type 2 diabetes mellitus].
    Li GW, Pan CY, Gao Y, Yuan SY, Yang WY, Xing XY, Tian H, Guo XH, Li HB.
    Zhonghua Nei Ke Za Zhi; 2004 Jul; 43(7):510-4. PubMed ID: 15312405
    [Abstract] [Full Text] [Related]

  • 15. Sustained-release versus immediate-release glipizide for treatment of type 2 diabetes mellitus in chinese patients: A randomized, double-blind, double-dummy, parallel-group, 12-week clinical study.
    Hsieh SH, Lin JD, Cheng HY, Ho C, Liou MJ.
    Clin Ther; 2006 Sep; 28(9):1318-26. PubMed ID: 17062305
    [Abstract] [Full Text] [Related]

  • 16. Normal insulin response to short-term intense exercise is abolished in Type 2 diabetic patients treated with gliclazide.
    Szewieczek J, Dulawa J, Strzałkowska D, Batko-Szwaczka A, Hornik B.
    J Diabetes Complications; 2009 Sep; 23(6):380-6. PubMed ID: 18394931
    [Abstract] [Full Text] [Related]

  • 17. Gliclazide in the treatment of obese non-insulin dependent diabetic patients.
    Seshiah V, Venkataraman S, Suresh K.
    J Assoc Physicians India; 1993 Jun; 41(6):367-8. PubMed ID: 8005974
    [Abstract] [Full Text] [Related]

  • 18. Effect of exenatide on 24-hour blood glucose profile compared with placebo in patients with type 2 diabetes: a randomized, double-blind, two-arm, parallel-group, placebo-controlled, 2-week study.
    Schwartz SL, Ratner RE, Kim DD, Qu Y, Fechner LL, Lenox SM, Holcombe JH.
    Clin Ther; 2008 May; 30(5):858-67. PubMed ID: 18555933
    [Abstract] [Full Text] [Related]

  • 19. Impact of the short-term, intense exercise on postprandial glycemia in type 2 diabetic patients treated with gliclazide.
    Szewieczek J, Dulawa J, Strzałkowska D, Hornik B, Kawecki G.
    J Diabetes Complications; 2007 May; 21(2):101-7. PubMed ID: 17331858
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.